Cargando…
Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study
RATIONALE & OBJECTIVE: Individuals with IgA vasculitis nephritis (IGAVN) may develop rapidly progressive glomerulonephritis and/or nephrotic-range proteinuria, which are associated with worse prognosis. We report our experience of treatment of children with IGAVN with nephrotic-range proteinuria...
Autores principales: | Samsonov, Dmitry, Zolotnitskaya, Anna, Matloff, Robyn, Pereira, Tanya, Solomon, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490199/ https://www.ncbi.nlm.nih.gov/pubmed/36159165 http://dx.doi.org/10.1016/j.xkme.2022.100534 |
Ejemplares similares
-
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015) -
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014) -
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
por: Du, Bing, et al.
Publicado: (2017) -
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
por: Hogg, Ronald J, et al.
Publicado: (2004) -
Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials
por: Zheng, Jian-Nan, et al.
Publicado: (2018)